Bethanechol chloride |
![]() Last updated: 15/09/2025 |
![]() |
(Not known by any other names) |
|
![]() |
|
A parasympathomimetic agent used used in veterinary medicine to help alleviate urine retention | |
---|---|---|
|
Relief of urine retention | |
|
Cats; Dogs; Horses |
Approval status |
|
Not approved | |
---|---|---|
|
Not approved |
Chemical structure |
|
Bethanechol chloride exhibits optical isomerism, due to the presence of a chiral centre in its molecular structure. The molecule contains a quaternary ammonium group attached to a chiral carbon, which allows for the existence of two enantiomers: (R)-bethanechol chloride and (S)-bethanechol chloride. In practice, bethanechol is typically administered as a racemic mixture. | |
---|---|---|
|
C₇H₁₇ClN₂O₂ | |
|
CC(C[N+](C)(C)C)OC(=O)N.[Cl-] | |
|
- | |
|
XXRMYXBSBOVVBH-UHFFFAOYSA-N | |
|
InChI=1S/C7H16N2O2.ClH/c1-6(11-7(8)10)5-9(2,3)4;/h6H,5H2,1-4H3,(H-,8,10);1H | |
|
Yes |
General status |
|
GI stimulant, Medicinal drug | |
---|---|---|
|
Choline carbamate drug; Quaternary ammonium compound | |
|
- | |
|
- | |
|
Synthetic | |
|
Bethanechol is a direct muscarinic agonist and stimulates the parasympathetic nervous system by binding to postganglionic muscarinic receptors | |
|
[Muscarinic acetylcholine receptor M3, Agonist], [Muscarinic acetylcholine receptor M5, Agonist] | |
|
590-63-6 | |
|
209-686-8 | |
|
- | |
|
- | |
|
11548 | |
|
Nervous system: Choline esters | |
|
QN07AB02 | |
|
No | |
|
- | |
|
196.67 | |
|
- | |
|
2-carbamoyloxypropyl(trimethyl)azanium;chloride | |
|
- | |
|
- | |
|
- | |
|
- | |
|
A slightly hygroscopic and polymorphic colorless crystalline powder with a slight, amine-like smell |
Commercial |
|
|
|||
---|---|---|---|---|
|
Current | |||
|
1935, first synthesised | |||
|
|
|||
|
|
|||
|
May be administered orally or via subcutaneous injection | |||
|
The production of bethanechol chloride involves synthesising a quaternary ammonium compound through a series of controlled chemical reactions. The process typically starts with choline derivatives, such as methyl chloride choline, which are reacted with chloroform in a cooled reaction vessel at around 0 DegC. To this mixture, solid phosgene is added in batches while stirring, initiating the formation of the carbamate structure. A catalyst is introduced after each phosgene addition to facilitate the reaction. The resulting intermediate undergoes further refinement to yield bethanechol, which is then converted into its chloride salt form for pharmaceutical use. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
331 | E4 E = Manufacturers safety data sheets 4 = Verified data |
Moderate | ||||||||
|
- | - | - | ||||||||
|
217 | E4 E = Manufacturers safety data sheets 4 = Verified data |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known metabolites |
None
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
1500 | E4 E = Manufacturers safety data sheets Rat4 = Verified data |
Moderate | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
1500 | E4 E = Manufacturers safety data sheets Rat4 = Verified data |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Mainly eliminated, unchanged, through renal excretion | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
May cause gastrointestinal disturbance and include vomiting, diarrhea |
Handling issues |
|
|
|||
---|---|---|---|---|
|
Not oxidising or explosive Incompatible with strong oxidising agents Hazardous reaction possible when in contact with nitrites, nitrates or nitrous acid |
|||
|
Health: H302 | |||
|
- | |||
|
Not regulated | |||
|
- | |||
|
The product is chemically stable under ambient conditions |
|
![]() |
|
|
||
---|---|---|---|
|
bethanechol chloride | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 15/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |